Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Radiotherapy and Oncology

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.radonc.2015.05.001PMID 25998804
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma.

  2014cited by this paper
• DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.

  2014cited by this paper
• Connective tissue of cervical carcinoma xenografts: Associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI

  2014cited by this paper
• Functional Imaging to Predict Tumor Response in Locally Advanced Cervical Cancer

  2013cited by this paper
• The Microenvironment of Cervical Carcinoma Xenografts: Associations with Lymph Node Metastasis and Its Assessment by DCE-MRI.

  2013cited by this paper
• Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.

  2012cited by this paper
• Biological predictors of cervical cancer response to radiation therapy.

  2012cited by this paper
• Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.

  2012cited by this paper
• Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI.

  2012cited by this paper
• Dynamic contrast‐enhanced‐MRI of tumor hypoxia

  2012cited by this paper
• Functional Imaging for Assessing Tumor Response in Cancer of the Cervix

  2011cited by this paper
• Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: pharmacokinetic analysis and correlation to tumor histomorphology.

  2010cited by this paper
• Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer.

  2010cited by this paper
• A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer.

  2009cited by this paper
• Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer

  2009cited by this paper
• Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.

  2009cited by this paper
• Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.

  2009cited by this paper
• Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix

  2009cited by this paper
• Imaging hemodynamics

  2008cited by this paper
• Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy.

  2007cited by this paper
• Hypoxia in cancer: significance and impact on clinical outcome

  2007cited by this paper
• The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.

  2006cited by this paper
• Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

  2006cited by this paper
• Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer

  2006cited by this paper
• OsiriX: An Open-Source Software for Navigating in Multidimensional DICOM Images

  2004cited by this paper
• Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.

  2002cited by this paper
• Tumor size and oxygenation are independent predictors of nodal diseases in patients with cervix cancer.

  2001cited by this paper
• Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd‐DTPA‐enhanced MR imaging

  2001cited by this paper
• Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

  2001cited by this paper
• Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy.

  2000cited by this paper
• Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization.

  2000cited by this paper
• Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix.

  2000cited by this paper
• Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols

  1999cited by this paper
• Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.

  1998cited by this paper
• Oxygenation predicts radiation response and survival in patients with cervix cancer.

  1998cited by this paper
• Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix.

  1998cited by this paper
• Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.

  1997cited by this paper
• Tumor oxygenation: a matter of supply and demand.

  1996cited by this paper
• Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

  1993cited by this paper

• Correlation of Ktrans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy

  2024cites this paper
• The Utility of Contrast-Enhanced Magnetic Resonance Imaging in Uterine Cervical Cancer: A Systematic Review

  2023cites this paper
• Functional Magnetic Resonance Imaging in Cervical Cancer Diagnosis and Treatment.

  2023cites this paper
• Assessment of Early Response to Lung Cancer Chemotherapy by Semiquantitative Analysis of Dynamic Contrast-Enhanced MRI

  2022cites this paper
• Assessment of Hypoxic Tissue Fraction and Prediction of Survival in Cervical Carcinoma by Dynamic Contrast-Enhanced MRI

  2021cites this paper
• Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy

  2021cites this paper
• Impact of hypoxia on cervical cancer outcomes

  2021cites this paper
• DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses

  2020cites this paper
• DCE-MRI of Tumor Hypoxia and Hypoxia-Associated Aggressiveness

  2020cites this paper
• Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2–IIA2 cervical cancers

  2020cites this paper
• The clinical utility of imaging methods used to measure hypoxia in cervical cancer.

  2020cites this paper
• Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model

  2019cites this paper
• What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?

  2019cites this paper
• DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma.

  2018cites this paper
• Multicystic mucinous adenocarcinoma of the uterine cervix compared with benign multicystic lesions: Multiparametric MR features

  2018cites this paper
• Evaluation of short‐ and long‐term efficacy of chemoradiotherapy for advanced cervical cancer using HSP70 protein combined with multimodal MRI

  2018cites this paper
• Medical physics in radiation Oncology: New challenges, needs and roles.

  2017cites this paper
• The value of advanced MRI techniques in the assessment of cervical cancer: a review

  2017cites this paper
• Evaluation of short-and long-term efficacy of chemoradiotherapy for advanced cervical cancer using HSP 70 protein combined with multimodal MRI † Running title : HSP 70 and multimodal MRI for cervical cancer

  2017cites this paper
• Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer

  2017cites this paper
• Hypoxia in cervical cancer: from biology to imaging

  2017cites this paper
• What’s New in Imaging for Gynecologic Cancer?

  2017cites this paper
• Dynamic contrast-enhanced MRI in determining histological type of cervical cancer

  2016cites this paper
• Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation

  2016cites this paper
• UvA-DARE ( Digital Academic Repository ) Optimization of adaptive radiation therapy in cervical cancer : Solutions for photon and proton therapy

  2016cites this paper
• Functional MR imaging in gynecologic malignancies: current status and future perspectives

  2016cites this paper
• Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma

  2016cites this paper